Literature DB >> 29863788

Mix and match of the tumor metastasis suppressor Nm23 protein isoforms in vitro and in vivo.

Clement M Potel1,2, Domenico Fasci1,2, Albert J R Heck1,2.   

Abstract

Nm23/NME was identified 30 years ago as the first metastatic gene suppressor family. Despite extensive studies, the mechanism of action behind the observed antimetastatic potential of Nm23 has remained largely unresolved. Human Nm23 is present in various isoforms, of which Nm23-H1 and Nm23-H2 are by far the most dominant. Both isoforms are multifunctional enzymes involved in important cellular processes, through their nucleic acid binding ability, their protein-protein interactions and/or their histidine kinase activity. Although Nm23-H1 and Nm23-H2 exhibit 88% sequence homology, they often are considered to have distinct biological functions. Here, we developed an efficient and robust purification protocol to pull-down Nm23 isoforms in their native state. We applied this protocol to purify both overexpressed isoform pure as well as endogenous Nm23 proteins from several human cell lines and mouse brain tissue. Subsequent native mass spectrometry (MS) analysis revealed that all purified Nm23 samples form hexamers, whereby the endogenous protein assembly is primarily present as heterohexamers formed by statistical association of the Nm23-H1 and Nm23-H2 isoforms. Therefore, we conclude that isoform-pure hexameric Nm23 complexes scarcely exist in vivo. We also used native and top-down MS to investigate the histidine autophosphorylation activity of purified Nm23 assemblies. Our data in fine challenge the biological relevance of studying the genes/proteins Nm23-H1 and Nm23-H2 individually.
© 2018 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990NMEzzm321990; Nm23; histidine phosphorylation; native mass spectrometry; nucleoside diphosphate kinase

Mesh:

Substances:

Year:  2018        PMID: 29863788     DOI: 10.1111/febs.14525

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.

Authors:  Imran Khan; Brunilde Gril; Patricia S Steeg
Journal:  Cancer Res       Date:  2019-07-16       Impact factor: 12.701

Review 2.  High-Resolution Native Mass Spectrometry.

Authors:  Sem Tamara; Maurits A den Boer; Albert J R Heck
Journal:  Chem Rev       Date:  2021-08-20       Impact factor: 72.087

Review 3.  NME/NM23/NDPK and Histidine Phosphorylation.

Authors:  Kevin Adam; Jia Ning; Jeffrey Reina; Tony Hunter
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

Review 4.  Structure, Folding and Stability of Nucleoside Diphosphate Kinases.

Authors:  Florian Georgescauld; Yuyu Song; Alain Dautant
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

Review 5.  Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation.

Authors:  Bokyung Kim; Kong-Joo Lee
Journal:  Exp Mol Med       Date:  2021-03-22       Impact factor: 8.718

Review 6.  The Complex Functions of the NME Family-A Matter of Location and Molecular Activity.

Authors:  Uwe Schlattner
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

7.  The Subcellular Localization and Oligomerization Preferences of NME1/NME2 upon Radiation-Induced DNA Damage.

Authors:  Martina Radić; Marko Šoštar; Igor Weber; Helena Ćetković; Neda Slade; Maja Herak Bosnar
Journal:  Int J Mol Sci       Date:  2020-03-29       Impact factor: 5.923

8.  Nme1 and Nme2 genes exert metastasis-suppressor activities in a genetically engineered mouse model of UV-induced melanoma.

Authors:  Nidhi Pamidimukkala; Gemma S Puts; M Kathryn Leonard; Devin Snyder; Sandrine Dabernat; Edward C De Fabo; Frances P Noonan; Andrzej Slominski; Glenn Merlino; David M Kaetzel
Journal:  Br J Cancer       Date:  2020-10-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.